share_log

HC Wainwright & Co. Reiterates Buy on Axsome Therapeuticsto Buy

Benzinga ·  Dec 31, 2024 20:38

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Axsome Therapeutics (NASDAQ:AXSM) from Buy to Buy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment